Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$34.5 - $42.19 $1.21 Million - $1.48 Million
35,000 New
35,000 $1.47 Million
Q3 2022

Nov 14, 2022

BUY
$46.5 - $79.14 $129,363 - $220,167
2,782 Added 35.62%
10,593 $499,000
Q2 2022

Aug 15, 2022

BUY
$63.06 - $84.75 $492,561 - $661,982
7,811 New
7,811 $560,000
Q1 2022

May 16, 2022

SELL
$74.15 - $99.36 $152,600 - $204,482
-2,058 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$86.01 - $102.89 $177,008 - $211,747
2,058 New
2,058 $211,000
Q3 2021

Nov 15, 2021

SELL
$84.7 - $96.31 $494,139 - $561,872
-5,834 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$76.44 - $89.57 $445,950 - $522,551
5,834 New
5,834 $522,000
Q1 2020

May 15, 2020

SELL
$32.64 - $73.63 $525,471 - $1.19 Million
-16,099 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$48.0 - $59.55 $772,752 - $958,695
16,099 New
16,099 $957,000

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Centiva Capital, LP Portfolio

Follow Centiva Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.